Related Experiment Video
Updated: Oct 31, 2025

An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
Published on: December 3, 2020
Intestinal permeability in type 1 diabetes: An updated comprehensive overview
Mia Øgaard Mønsted1, Nora Dakini Falck1, Kristina Pedersen1
1The Bartholin Institute, Department of Pathology, Rigshospitalet, Copenhagen N, Denmark.
Increased intestinal permeability is consistently observed in type 1 diabetes (T1D). This review synthesizes evidence from human and animal studies, highlighting the gut barrier
Area of Science:
- Immunology
- Gastroenterology
- Endocrinology
Background:
- Type 1 diabetes (T1D) etiopathogenesis involves genetic and environmental factors.
- The gastrointestinal (GI) tract is a key interface for environmental influences.
- Barrier defects in the GI tract may allow diabetogenic antigens to trigger beta-cell autoimmunity.
Purpose of the Study:
- To provide a comprehensive overview of intestinal permeability in T1D.
- To analyze findings across various methodologies in human and animal models.
- To identify consistencies and variations in intestinal permeability research in T1D.
Main Methods:
- Review of in vivo and ex vivo permeability studies.
- Analysis of zonulin, molecular permeability, and blood markers.
- Inclusion of data from human patients and animal models of T1D.
Main Results:
- Consistent evidence indicates increased intestinal permeability in T1D.
- Intestinal permeability in animal models varies by age and strain.
- Dietary interventions impacting diabetes incidence also affect intestinal permeability in models.
Conclusions:
- Increased intestinal permeability is a significant factor in T1D development.
- Methodological and experimental design choices are crucial in T1D permeability studies.
- A strong association exists between heightened intestinal permeability and T1D pathogenesis.
More Related Videos
09:24Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice using a Standardized Intestinal Loop Model
Published on: February 11, 2021
05:14Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran
Published on: November 18, 2022
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...